GWA Award 2025 Recap
On November 7, 2025, leaders, innovators, and global health advocates gathered at the historic Harvard Club of Boston for an unforgettable evening celebrating women advancing health innovation worldwide. The Global Women Asia Groundbreakers Award Gala brought together distinguished guests, industry pioneers, and the newly welcomed cohort of 2025 GWA Fellows for a night honoring transformative leadership and impact.
Global Women Asia Women in Health Innovation Groundbreakers award ceremony recap
GWA 2025 Gala Photo Gallery
Honoree Video Highlights
Roberta Lipson
Founder of United Family Healthcare (UFH), Roberta Lipson is a 40-year pioneer in China’s healthcare industry. She co-founded Chindex in 1981, growing it from a medical equipment distributor into China’s first and largest foreign-invested healthcare system, and took the company public twice. She now serves as Vice Chair of New Frontier Health and remains a key voice in U.S.–China business relations. She also founded the United Foundation for China’s Health, a nonprofit providing critical care to underserved communities across China.
American India Foundation
The American India Foundation’s Maternal and Newborn Survival Initiative (MANSI) is a public-private program that reduces maternal and child mortality in rural, underserved communities across India. By training and supporting frontline health workers to deliver effective, low-cost, home-based care, MANSI improves outcomes for pregnant women, newborns, and children under five. To date, it has served over 500,000 pregnant women, supported more than 300,000 children and newborns, and empowered 250,000 adolescent girls with health, education, and life skills.
Takeda
Takeda is committed to creating better health for people and a brighter future for the world. We develop life-transforming treatments across gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. In partnership with global collaborators, we advance innovative therapies and elevate the patient experience through a dynamic R&D pipeline. As a leading values-based, research-driven biopharmaceutical company headquartered in Japan, Takeda is guided by a long-standing commitment to patients, people, and the planet, with employees across nearly 80 countries carrying forward more than two centuries of purpose and values.
Explore the full event program for speaker details and honorees.
